Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab

Single-agent bevacizumab treatment in multiresistant EOC appears to be a valuable treatment option with acceptable side-effects. Cell-free DNA showed independent prognostic importance in patients treated with bevacizumab and could be applied as an adjunct for treatment selection.